Back to Search Start Over

Differences in Cerebral Tissue Oxygenation in Preterm Neonates Receiving Adult or Cord Blood Red Blood Cell Transfusions

Authors :
Pellegrino, Claudio
Papacci, Patrizia
Beccia, Flavia
Serrao, Francesca
Cantone, Giulia Vanina
Cannetti, G.
Giannantonio, Carmen
Vento, Giovanni
Teofili, Luciana
Pellegrino C.
Papacci P. (ORCID:0000-0001-8236-7460)
Beccia F.
Serrao F.
Cantone G. V.
Giannantonio C.
Vento G. (ORCID:0000-0002-8132-5127)
Teofili L. (ORCID:0000-0002-7214-1561)
Pellegrino, Claudio
Papacci, Patrizia
Beccia, Flavia
Serrao, Francesca
Cantone, Giulia Vanina
Cannetti, G.
Giannantonio, Carmen
Vento, Giovanni
Teofili, Luciana
Pellegrino C.
Papacci P. (ORCID:0000-0001-8236-7460)
Beccia F.
Serrao F.
Cantone G. V.
Giannantonio C.
Vento G. (ORCID:0000-0002-8132-5127)
Teofili L. (ORCID:0000-0002-7214-1561)
Publication Year :
2023

Abstract

IMPORTANCE Repeated transfusions in preterm neonates with anemia of prematurity replace fetal hemoglobin (HbF) with adult Hb (HbA), which has a low oxygen affinity. The reduction of HbF is associated with a higher incidence of retinopathy of prematurity (ROP). OBJECTIVE To assess whether HbF and HbA are differently associated with cerebral tissue oxygenation in preterm neonates. DESIGN, SETTING, AND PARTICIPANTS This cohort study was a single-center, pilot study on cerebral oxygenation kinetics in preterm neonates with a gestational age between 24.0 weeks and 27.9 weeks who were admitted to the neonatal intensive care unit of Policlinico Universitario A. Gemelli IRCCS from December 27, 2021, to May 15, 2023. This study was ancillary to the ongoing, double-blind, multicenter Umbilical or Adult Donor Red Blood Cells in Extremely Low Gestational Age Neonates and Retinopathy of Prematurity (BORN) randomized clinical trial. The BORN trial outcome was ROP severity in neonates randomized to receive standard packed red blood cell (PRBC) transfusions obtained from RBCs of adult donors (A-RBCs) or from cord blood (CB-RBCs). According to standard procedures at the institute’s neonatal intensive care unit, patients concurrently received continuous cerebral near-infrared spectroscopy (NIRS) monitoring. This cohort study was not prespecified in the trial protocol. EXPOSURE Transfusion with A-RBCs or CB-RBCs. MAIN OUTCOMES AND MEASURES The main outcome was the kinetics of cerebral regional oxygen saturation (crSO2) and cerebral fraction of tissue oxygen extraction (cFTOE) associated with A-RBC or CB-RBC transfusions. Cerebral NIRS monitoring was performed by neonatologists and nurses, who were blinded to the PRBC type. The NIRS monitoring was conducted starting with the blood product order, during transfusion, and for the subsequent 24 hours after transfusion completion. The mean treatment effects of A-RBCs or CB-RBCs were quantified using a linear mixed model for repeated measure

Details

Database :
OAIster
Notes :
English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1439665666
Document Type :
Electronic Resource